首页> 外文期刊>American Journal of Ophthalmology: The International Journal of Ophthalmology >Laser-assisted in situ keratomileusis in high levels of myopia with the amaris excimer laser using optimized aspherical profiles
【24h】

Laser-assisted in situ keratomileusis in high levels of myopia with the amaris excimer laser using optimized aspherical profiles

机译:使用优化的非球面轮廓的amaris准分子激光在高度近视中进行激光辅助的原位角膜磨镶术

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Purpose: To evaluate the clinical outcomes of laser-assisted in situ keratomileusis (LASIK) surgery for the correction of high myopia using a new generation of excimer laser (500-Hz repetition rate) and optimized aspherical profiles. Design: Retrospective interventional case series. Methods: Retrospective study including 51 eyes of 32 patients (age range 23-61 years) with high levels of myopia or myopic astigmatism (spherical equivalent <8.5 diopters [D]). All cases underwent uneventful LASIK surgery using the sixth-generation excimer laser Amaris from Schwind and a femtosecond platform for flap creation. Postoperative changes in visual acuity and refraction were recorded and analyzed during a 6-month follow-up. Results: A significant improvement of about 15 logMAR lines was observed in uncorrected distance visual acuity (UCDVA) at 3 months after surgery (P <.01), with no significant changes afterwards (P =.61). This improvement was consistent with a significant reduction of manifest refraction (P <.01). Best corrected distance visual acuity (BCDVA) remained unchanged or improved in 98% of eyes at 3 months postoperatively, with only 1 eye losing 1 logMAR line of BCDVA. A similar distribution of BCDVA data was observed at 6 months postoperatively. A total of 84.3% of eyes had a postoperative spherical equivalent within ±0.50 D of emmetropia. A limited but significant induction of primary spherical aberration and coma was also found (P <.01). LASIK enhancement was required during the follow-up in only 4 eyes (7.8%). Conclusions: LASIK for high myopia using optimized aspherical profiles and the Amaris excimer laser is a safe, effective, and predictable procedure.
机译:目的:使用新一代准分子激光(500 Hz重复频率)和优化的非球面轮廓,评估激光辅助原位角膜磨镶术(LASIK)矫正高度近视的临床效果。设计:回顾性介入病例系列。方法:回顾性研究包括32例(年龄范围23-61岁)高度近视或近视散光(等效球镜<8.5屈光度[D])的51眼。所有病例均使用来自施温德(Schwind)的第六代准分子激光Amaris和飞秒平台制作皮瓣,进行了无畸形的LASIK手术。在6个月的随访期间,记录并分析了术后视力和屈光度的变化。结果:术后3个月的未矫正远视力(UCDVA)观察到约15 logMAR系的显着改善(P <.01),此后无显着变化(P = .61)。这种改善与明显的屈光度降低相一致(P <.01)。术后3个月,最佳矫正远视力(BCDVA)在98%的眼睛中保持不变或有所改善,只有1眼丧失了1 logMAR BCDVA系。术后6个月观察到类似的BCDVA数据分布。总共84.3%的眼睛术后眼球等效值在正视眼的±0.50 D之内。还发现了有限但重要的原发性球差和昏迷感(P <.01)。随访期间仅4只眼(7.8%)需要进行LASIK增强。结论:使用优化的非球面轮廓和Amaris准分子激光治疗高度近视的LASIK是一种安全,有效且可预测的手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号